Lewis, Russell E.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 1,556

Antifungal drug resistance of pathogenic fungi

Kontoyiannis, D. P., & Lewis, R. E. (2002) · The Lancet

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 553

Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods

Klepser, M. E., Ernst, E. J., Lewis, R. E., Ernst, M. E., & Pfaller, M. A. (1998) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 338

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007): Stable incidence but changing epidemiology of a still frequently lethal infection

Sipsas, N. V., Lewis, R. E., Tarrand, J., Hachem, R., Rolston, K. V., Raad, I. I., & Kontoyiannis, D. P. (2009) · Cancer

Antifungal resistance and susceptibilityNeutropenia and Cancer Infections

Cited by 269

Paradoxical Effect of Echinocandins across Candida Species In Vitro: Evidence for Echinocandin-Specific and Candida Species-Related Differences

Chamilos, G., Lewis, R. E., Albert, N., & Kontoyiannis, D. P. (2007) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 171

Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.

Ben-Ami, R., Garcia-Effron, G., Lewis, R. E., Gamarra, S., Leventakos, K., Perlin, D. S., & Kontoyiannis, D. P. (2011) · The Journal of Infectious Diseases

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 162

Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer

Chitasombat, M. N., Kofteridis, D. P., Jiang, Y., Tarrand, J., Lewis, R. E., & Kontoyiannis, D. P. (2012) · Journal of Infection

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 152

Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high‐risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation

Kontoyiannis, D. P., Chamilos, G., Lewis, R. E., Giralt, S., Cortes, J., Raad, I. I., Manning, J. T., & Han, X. (2007) · Cancer

Antifungal resistance and susceptibilityNeutropenia and Cancer Infections

Cited by 152

Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions

Lionakis, M. S., Lewis, R. E., & Kontoyiannis, D. P. (2018) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 145

The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy

Wiederhold, N. P., & Lewis, R. E. (2003) · Expert Opinion on Investigational Drugs

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 144

Attenuation of the Activity of Caspofungin at High Concentrations against Candida albicans : Possible Role of Cell Wall Integrity and Calcineurin Pathways

Wiederhold, N. P., Kontoyiannis, D. P., Prince, R. A., & Lewis, R. E. (2005) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 131

In Vitro Pharmacodynamics of Amphotericin B, Itraconazole, and Voriconazole against Aspergillus,Fusarium, and Scedosporium spp

Lewis, R. E., Wiederhold, N. P., & Klepser, M. E. (2005) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 129

Stimulated Innate Resistance of Lung Epithelium Protects Mice Broadly against Bacteria and Fungi

Evans, S. E., Scott, B. L., Clement, C. G., Larson, D. T., Kontoyiannis, D., Lewis, R. E., LaSala, P. R., Pawlik, J., Peterson, J. W., Chopra, A. K., et al. (2010) · American Journal of Respiratory Cell and Molecular Biology

Immune Response and InflammationImmune responses and vaccinations

Cited by 129

Lovastatin Has Significant Activity against Zygomycetes and Interacts Synergistically with Voriconazole

Chamilos, G., Lewis, R. E., & Kontoyiannis, D. P. (2006) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 121

Echinocandin Resistance in Candida Species: Mechanisms of Reduced Susceptibility and Therapeutic Approaches

Beyda, N. D., Lewis, R. E., & Garey, K. W. (2012) · Annals of Pharmacotherapy

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 109

High Resolution Computed Tomography Angiography Improves the Radiographic Diagnosis of Invasive Mold Disease in Patients With Hematological Malignancies

Stanzani, M., Sassi, C., Lewis, R. E., Tolomelli, G., Bazzocchi, A., Cavo, M., Vianelli, N., & Battista, G. (2015) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 91

Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999–2015

Heo, S. T., Tatara, A. M., Jiménez-Ortigosa, C., Jiang, Y., Lewis, R. E., Tarrand, J., Tverdek, F., Albert, N. D., Verweij, P. E., Meis, J. F., et al. (2017) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 67

Pretreatment with Empty Liposomes Attenuates the Immunopathology of Invasive Pulmonary Aspergillosis in Corticosteroid-Immunosuppressed Mice

Lewis, R. E., Chamilos, G., Prince, R. A., & Kontoyiannis, D. P. (2007) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 51

Inhibition of Candida parapsilosis Mitochondrial Respiratory Pathways Enhances Susceptibility to Caspofungin

Chamilos, G., Lewis, R. E., & Kontoyiannis, D. P. (2006) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 47

Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species

Chen, S. C.-A., Lewis, R. E., & Kontoyiannis, D. P. (2011) · Virulence

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 41

Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae

Bellanger, A.-P., Tatara, A. M., Shirazi, F., Gebremariam, T., Albert, N. D., Lewis, R. E., Ibrahim, A. S., & Kontoyiannis, D. P. (2016) · Journal of Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 41

Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus

Lewis, R. E., Liao, G., Hou, J., Prince, R. A., & Kontoyiannis, D. P. (2011) · Journal of Antimicrobial Chemotherapy

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 23

Comparison of oral immediate-release (IR) and extended-release (ER) metronidazole bactericidal activity against Bacteroides spp. using an in vitro model of infection

Lewis, R. E., Klepser, M. E., Ernst, E. J., Snabes, M. A., & Jones, R. N. (2000) · Diagnostic Microbiology and Infectious Disease

Antibiotics Pharmacokinetics and EfficacyAntibiotic Resistance in Bacteria

Cited by 15

Animal Models for Studying Triazole Resistance in Aspergillus fumigatus

Lewis, R. E., & Verweij, P. E. (2017) · The Journal of Infectious Diseases

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 13